TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹55 Cr | ₹21 Cr | ₹12 Cr | ₹7.62 Cr |
What is the latest Total Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹55 Cr |
| Mar2024 | ₹21 Cr |
| Mar2023 | ₹12 Cr |
| Mar2022 | ₹7.62 Cr |
How is Total Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹55 Cr | 163.62 | |
| Mar2024 | ₹21 Cr | 76.55 | |
| Mar2023 | ₹12 Cr | 55.64 | |
| Mar2022 | ₹7.62 Cr | - | |
Compare Total Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹363.0 Cr | 5.8% | 2.3% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹401,541.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹163,031.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,451.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,377.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,355.5 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 5.8% |
2.3% |
-3.2% |
| SENSEX | -0.4% |
-1.7% |
9.1% |
You may also like the below Video Courses